|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 14/62 | |
| A61K 38/28 |
| (11) | Number of the document | 2254906 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09722934.8 |
| Date of filing the European patent application | 2009-03-13 | |
| (97) | Date of publication of the European application | 2010-12-01 |
| (45) | Date of publication and mention of the grant of the patent | 2016-10-05 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2009/053017 |
| Date | 2009-03-13 |
| (87) | Number | WO 2009/115469 |
| Date | 2009-09-24 |
| (30) | Number | Date | Country code |
| 08102708 | 2008-03-18 | EP | |
| 08170231 | 2008-11-28 | EP |
| (72) |
MADSEN, Peter, DK
KJELDSEN, Thomas B rglum, DK
HOEG-JENSEN, Thomas, DK
JAKOBSEN, Palle, DK
TAGMOSE, Tina M ller, DK
GLENDORF, Tine, DK
KODRA, Jįnos Tibor, DK
GARIBAY, Patrick William, DK
PETERSEN, Jacob Sten, DK
|
| (73) |
Novo Nordisk A/S,
Novo Allé, 2880 Bagsvęrd,
DK
|
| (54) | PROTEASE STABILIZED, ACYLATED INSULIN ANALOGUES |
| PROTEASE STABILIZED, ACYLATED INSULIN ANALOGUES |